查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1304163

月经痛治疗市场:各类药物，各类型，各给药途径，各剂型，各流通管道，各地区- 市场规模，占有率，展望，机会分析，2023年～2030年

Menstrual Cramps Treatment Market, By Drug Class, By Type, By Route of Administration, By Dosage Form, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 205 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态

市场参与者正专注于增加无机策略，例如 月经痉挛治疗的合作，预计将在预测期内推动全球月经痉挛市场的增长。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球月经痛治疗市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球月经痛治疗市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球月经痛治疗市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球月经痛治疗市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场魅力分析
    • 市场机会
  • 产品发表
  • 市场趋势
  • 合併，收购，联盟
  • 法规指南和遵守
  • 主要的发展
  • PEST分析
  • 技术形势
  • 价格分析
  • 品牌分析
  • 投资与资金筹措
  • 设施的扩张

第4章 月经痛治疗的全球市场:冠状病毒(COVID-19)流行的影响

  • 政府的配合措施
  • COVID-19流行病学
  • 主要的发展

第5章 月经痛治疗的全球市场:各类药物，2018年～2030年

  • 止痛药
  • 抗胆碱药
  • 非类固醇消炎剂
  • 血液循环促进药
  • 其他(特别黄体激素剂)

第6章 月经痛治疗的全球市场:各类型，2018年～2030年

  • 原发性经痛
  • 续发性经痛

第7章 月经痛治疗药的全球市场:各给药途径，2018年～2030年

  • 口服剂
  • 注射剂
  • 局部
  • 其他(子宫内，其他)

第8章 月经痛治疗的全球市场:各剂型，2018年～2030年

  • 锭剂
  • 胶囊剂
  • 悬浮液
  • 其他(经皮吸收贴片，其他)

第9章 月经痛治疗的全球市场:各流通管道，2018年～2030年

  • 医院药局
  • 零售药局
  • 线上药局

第10章 月经痛治疗的全球市场:各地区，2018年～2030年

  • 北美
  • 美国
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他南美国家
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东
  • 非洲
  • 北非
  • 中非
  • 南非

第11章 竞争情形

  • Pfizer, Inc.
  • Ingelheim International GmbH
  • Bayer AG
  • Abbott
  • Cipla Inc
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Reddy's Laboratories Ltd
  • Almatica Pharma LLC.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Eisen Pharmaceutical Co.(Pvt.)Ltd
  • Emcure Pharmaceuticals
  • AbbVie
  • Sparsha Pharma International Pvt Ltd.
  • Hope Medicine(南京市)Co., Ltd

第12章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI5760

Menstrual cramps (dysmenorrhea) are throbbing or cramping pains in the lower abdomen. Many women have menstrual cramps just before and during their menstrual periods. Conditions such as endometriosis or uterine fibroids can cause menstrual cramps. Symptoms occurred like aching pain in lower abdomen, a feeling of pressure in belly, pain in hips, lower back, and inner thighs. To treat menstrual cramps, over-the-counter pain relievers such as NSAID's like ibuprofen (Advil), Naproxen sodium (Aleve) are used. Hormonal antagonists drugs such as MYFEMBREE (Pfizer) also used for the treatment of menstrual cramps.

Market Dynamics

Market players in the market are focusing on ncreasing inorganic strategies such as collaboration for menstrual cramp treatment is expected to drive the the global menstrual cramp market growth over the forecast period. For instance, on April 10, 2018, AbbVie, a global research and development-based biopharmaceutical company, and Neurocrine Biosciences, announced PDUFA (Prescription Drug User Fee Act) for Elagolix in endometriosis-associated pain.. Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It is administered orally, and is a short-acting molecule that blocks endogenous GnRH receptors in the pituitary gland.

Increasing prevalence of menstrual cramps is expected to drive the market growth over the forecast period. For instance, on January 14, 2022, article published by MDPI, stated that a study was conducted in Europe's Romania in prospective, analytical, observational and took place between 7 November 2019 and 30 January 2020. This study included a population of 1720 from five university centers throughout the country. Out of 1,720 participants, 1,349 (78.4%) had dysmenorrhea. The prevalence of dysmenorrhea, ranging from 16% to 91% has been reported. The most widely used drugs were non-steroidal anti-inflammatory drugs, utilized by 741 students (54.9%) has been reported.

Moreover, according to article published by International Journal of Womens Health, a study was conducted in Southern Ethiopia, the prevalence of primary dysmenorrhea among all the female students is 70% of population who reported.

Key features of the study:

  • This report provides in-depth analysis of the global menstrual cramps treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global menstrual cramps treatment market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co. (Pvt.) Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine (Nanjing) Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global menstrual cramps treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menstrual cramps treatments market

Detailed Segmentation:

  • Global Menstrual Cramp Treatment Market, By Drug Class:
    • Analgesics
    • Anticholinergic
    • Non-steroidal anti-inflammatory drugs (NSAIDs)
    • Haematinics
    • Others (Progestins, Among others)
  • Global Menstrual Cramp Treatment Market, By Type:
    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • Global Menstrual Cramp Treatment Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
    • Others (Intrauterine, Others)
  • Global Menstrual Cramp Treatment Market, By Dosage Form:
    • Tablet
    • Capsules
    • Suspension
    • Others (Transdermal Patch, Among others)
  • Global Menstrual Cramp Treatment Market, By Distribution channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Menstrual Cramps Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Pfizer Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ingelheim International GmbH PerkinElmer Inc.
    • Bayer AG
    • Abbott.
    • Cipla Inc
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Johnson & Johnson Services, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Almatica Pharma LLC.
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline Plc
    • Eisen Pharmaceutical Co. (Pvt.) Ltd.
    • Emcure Pharmaceuticals
    • AbbVie.
    • Sparsha Pharma International Pvt Ltd.
    • Hope Medicine (Nanjing) Co., Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Type
    • Market Snapshot, By Route of administration
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Market Trends
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Pricing Analysis
  • Brand Analysis
  • Investments and Funding
  • Facility Expansions

4. Global Menstrual Cramps Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Government Initiatives
  • COVID-19 Epidemiology
  • Key Developments

5. Global Menstrual Cramps Treatment Market, By Drug Class, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Anticholinergics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Non-steriodal anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Haematinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Progestins, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Menstrual Cramps Treatment Market, By Type, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Primary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Secondary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Menstrual Cramps Treatment Market, By Route of administration, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segments Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Intrauterine, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Menstrual Cramps Treatment Market, By Dosage Form, 2018 - 2030, (US$ Million)

  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Transdermal Patch, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Global Menstrual Cramps Treatment Market, By Distribution channel, 2018 - 2030, (US$ Million)

  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Global Menstrual Cramps Treatment Market, By Region, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cipla Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Reddy's Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Almatica Pharma LLC.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisen Pharmaceutical Co. (Pvt.) Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emcure Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sparsha Pharma International Pvt Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hope Medicine (Nanjing) Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

12. Section

  • Research Methodology
  • About Us